Delays in the delivery of vaccines: one by one, which laboratories are with delays

Few countries are starting to receive strong internal criticism for the delay in Distribution of vaccinations. As a result, governments are showing signs of impatience and are filing complaints with laboratories seeking an answer. Older delays, according to country complaints, are in the delivery of vaccines from Astrazeneca, Pfizer, Gamaleya Yes Sinovac.

The European Union (EU) is one of the leading companies when it comes to complaints. The bloc as a whole is trying to put pressure on pharmaceutical companies to deliver the doses of coronavirus vaccine they had pledged to deliver in the first quarter of the year, following announcements of delays of Pfizer Yes AstraZeneca.

The President of the European Council, Charles Michel, assured this Wednesday, January 27 that the laboratories would maintain the initial schedule of vaccine deliveries in the European Union from January 25, after Brussels intervene so that contracts are respected.

Delay in arrival of vaccines complicates Government plans

“We will do that the contracts are respected which have been validated by pharmaceutical laboratories and we are committed to transparency by using all the legal means at our disposal ”, declared Charles Michel on French radio Europe 1.

The President of the European Council insisted that from Brussels they had to “fight and slam the table“To seek clarification on the reasons why delays were announced and also asked companies to speak up transparently on why they sometimes had difficulties in the production line.

Astrazeneca is under pressure from Europe

AstraZeneca reported Friday to European Commission that after the approval of its vaccine against the coronavirus by the European Medicines Agency (EMA), which is expected at the end of the month, it will not be able to deliver the expected number of doses initially.

The European Commission (EC) has increased pressure on AstraZeneca after being dissatisfied with the pharmacist’s explanations of his delays in dispensing vaccines.

The persistence of the third wave and the arrival of more contagious variants of the coronavirus This prompted the new restrictions on mobility, there are additional problems in the production and delivery of the vaccines he had in the coming weeks, shading the light at the end of the tunnel the EU was beginning to see.

That same Sunday, the now former Prime Minister of Italy, Giuseppe Conte, announced that his country will undertake legal actions against the pharmaceutical Astrazeneca for reducing the batch of coronavirus vaccines, as it has already done with Pfizer Yes BioNtech for the same reasons.

In any event, most Member States confined themselves to “express your dissatisfaction“or discomfort and urge companies to speed up the distribution of injections and comply with the agreement.

Ecuador: presidential candidate says Alberto Fernández guaranteed him “millions of doses”

Pfizer with vaccine production problems

January 15th Pfizer confirmed a change in its production capacity for the coronavirus vaccine that would reduce the number of them that would be distributed in Europe in the coming weeks.

The firm said in a statement that “it is working hard to deliver more doses of those initially planned for this year “and that it must modify the production process to increase its capacity, which” requires additional regulatory approvals “.

“While this will have a temporary impact on shipments in late January and early February, it will result in a significant increase in the doses available to patients in late February and March,” the drugmaker said.

The pharmaceutical reported that “there will be delays for a week: this week we are now”, but next week’s deliveries are expected to return to normal and, despite the problems, Pfizer has committed to Brussels to deliver the doses by March originally signed.

After two postponements, the third flight left for Russia in search of more vaccines

Gamaleya and Sputnik V: the priority is internal vaccination

“As in any business relationship, one of the two parties can be delayed, there is a signed contract that must be respected,” they expressed from the Ministry of Health to The nation, although they ruled out the possibility of another claim.

“You understand the delay by context. They are vaccinate its population, at the same time generating other contracts such as with Mexico “, they argued from the portfolio led by González García on the vaccine Sputnik V.

Sinovac: claim by Brazil and Turkey

he New York Times titled his note “China wanted to show off its vaccines. The blow turned against him“They pointed out about Sinovac that” the delays, the inconsistent data, irregularities in disclosure and the country’s attacks on Western rivals have marred its ambitious effort to market itself as a global healthcare leader. “

Since Brazil Yes turkey they complained that Chinese companies were slow to ship dosages and ingredients.

In turkey, the government had initially promised that ten million doses of the vaccine Sinovac they would arrive in December. Only three million arrived in early January, Turkish Health Minister Fahrettin Koca told NYT.

In BrazilHealth Minister Eduardo Pazuello said China “is not moving fast enough with regard to the documents needed to export raw materials to Brazil”.

In PhilippinesSome lawmakers have criticized the government’s decision to purchase vaccines made by Sinovac.

EA / FF